Physician profile
William Schnapp
NPI 1699938795
$21,275.25
in general payments reported to CMS, 2019-2025
20 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $573 · 2021: $478 · 2022: $5,604 · 2023: $12K · 2024: $747 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,010 · Food and Beverage: $3,207 · Travel and Lodging: $2,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,010.00 |
| Food and Beverage | $3,207.01 |
| Travel and Lodging | $2,044.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13,970.04 | 2021-2025 | Intellis Adaptivestim, Osteocool Rf Ablation System, Interstim |
| Relievant Medsystems, INC. | $2,316.42 | 2020-2023 | Intracept |
| Spinal Simplicity, LLC | $1,594.02 | 2022-2025 | Ha Minuteman G3-R |
| Nevro Corp. | $1,355.96 | 2019-2024 | Senza |
| Boston Scientific Corporation | $806.99 | 2019-2025 | Intracept, General - Pain Management |
| Spr Therapeutics, INC | $196.78 | 2022-2025 | Sprint Pns System |
| Medtronic USA, INC. | $191.44 | 2019-2020 | |
| Abbott Laboratories | $172.36 | 2025 | Eterna |
| Si-Bone, INC. | $111.65 | 2019 | |
| Globus Medical, INC. | $100.42 | 2025 | Senza |
| Neurasignal INC. | $95.00 | 2024 | |
| Abbvie INC. | $84.73 | 2025 | |
| Vertos Medical, INC. | $73.92 | 2024 | Mild Device Kit |
| Allergan, INC. | $57.63 | 2019-2021 | |
| Lundbeck LLC | $33.25 | 2024 | Vyepti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $26.61 | 2024 | Qutenza |
| Mauna Kea Technologies, INC. | $26.53 | 2024 | |
| Insightec,INC | $25.01 | 2025 | Exablate |
| Biohaven Pharmaceutical Holding Company LTD. | $18.44 | 2022 | |
| Pfizer INC. | $18.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Schnapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.